DrugPatentWatch Database Preview
JANSSEN PRODS Company Profile
What is the competitive landscape for JANSSEN PRODS, and when can generic versions of JANSSEN PRODS drugs launch?
There are twenty-two US patents protecting JANSSEN PRODS drugs.
There are five hundred and fifty patent family members on JANSSEN PRODS drugs in forty-nine countries and one hundred and twenty-seven supplementary protection certificates in thirteen countries.
Summary for JANSSEN PRODS
| International Patents: | 550 |
| US Patents: | 22 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 6 |
Drugs and US Patents for JANSSEN PRODS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Prods | PREZISTA | darunavir ethanolate | TABLET;ORAL | 021976-003 | Oct 21, 2008 | DISCN | Yes | No | 7,470,506*PED | ➤ Sign Up | Y | ➤ Sign Up | |||
| Janssen Prods | PREZISTA | darunavir ethanolate | TABLET;ORAL | 021976-003 | Oct 21, 2008 | DISCN | Yes | No | 8,597,876*PED | ➤ Sign Up | Y | ➤ Sign Up | |||
| Janssen Prods | EDURANT | rilpivirine hydrochloride | TABLET;ORAL | 202022-001 | May 20, 2011 | RX | Yes | Yes | 7,638,522 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Janssen Prods | PREZISTA | darunavir ethanolate | TABLET;ORAL | 021976-001 | Jun 23, 2006 | DISCN | Yes | No | 8,597,876*PED | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for JANSSEN PRODS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Janssen Prods | PREZISTA | darunavir ethanolate | SUSPENSION;ORAL | 202895-001 | Dec 16, 2011 | 6,335,460*PED | ➤ Sign Up |
| Janssen Prods | PREZISTA | darunavir ethanolate | TABLET;ORAL | 021976-002 | Feb 25, 2008 | RE43802*PED | ➤ Sign Up |
| Janssen Prods | PREZISTA | darunavir ethanolate | TABLET;ORAL | 021976-002 | Feb 25, 2008 | 6,703,403*PED | ➤ Sign Up |
| Janssen Prods | PREZISTA | darunavir ethanolate | TABLET;ORAL | 021976-002 | Feb 25, 2008 | RE42889*PED | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for JANSSEN PRODS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 800 mg | ➤ Subscribe | 2013-05-14 |
Non-Orange Book US Patents for JANSSEN PRODS
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 8,067,449 | Modulators of pharmacokinetic properties of therapeutics | ➤ Sign Up |
| 7,608,590 | HCV NS-3 serine protease inhibitors | ➤ Sign Up |
| 7,956,063 | Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl- ]amino]benzonitrile | ➤ Sign Up |
| 9,139,541 | Modulators of pharmacokinetic properties of therapeutics | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for JANSSEN PRODS Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Norway | 2012010 | ➤ Sign Up |
| Eurasian Patent Organization | 200601400 | ➤ Sign Up |
| Serbia | 55195 | ➤ Sign Up |
| South Korea | 101539245 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for JANSSEN PRODS Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 90002-8 | Sweden | ➤ Sign Up | PRODUCT NAME: COBICISTAT OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND ATAZANAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR ATAZANAVIR SULFATE; REG. NO/DATE: EU/1/15/1025 20150715 |
| 0150041 00168 | Estonia | ➤ Sign Up | PRODUCT NAME: RILPIVIRIINI (VESINIKKLORIIDSOOLANA) JA TENOFOVIIR-;REG NO/DATE: EU/1/11/737/001-002 28.11.2011 |
| 2016038 | Lithuania | ➤ Sign Up | PRODUCT NAME: ELVITEGRAVIRAS + KOBICISTATAS + EMTRICITABINAS + TENOFOVIRALAFENAMIDAS; REGISTRATION NO/DATE: EU/1/15/1061 20151119 |
| 0859 | Netherlands | ➤ Sign Up | PRODUCT NAME: COBICISTAT, DAN WEL EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN ATAZANAVIR, DAN WEL EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, IN HET BIJZONDER ATAZANAVIRSULFAAT; REGISTRATION NO/DATE: EU/1/15/1025 20150715 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
